在纤维化间歇性肺病中,病理机制和新药点在纤维化间歇性肺病中
Yasuhiko Nishioka1, Jun Araya2, Yoshiya Tanaka3
1Tokushima University, Tokushima, Japan.
Inflammation and regeneration
|July 18, 2024
概括
渐进性纤维化间歇性肺病 (ILDs) 涉及复杂的机制,如纤维细胞激活. 新的药物标正在出现,以对抗这种不可逆转的肺部疾病.
科学领域:
- 肺部医学 肺部医学
- 纤维化研究 纤维化研究
- 细胞生物学 细胞生物学
背景情况:
- 间歇性肺部疾病 (ILDs) 涵盖了由肺炎和纤维化标志的各种疾病.
- 一部分ILD患者患有渐进性纤维化,导致不可逆转的肺功能下降和不良结果.
研究的目的:
- 审查目前有关导致渐进性纤维化ILD的病理机制的知识.
- 要突出最近的进展和新的治疗目标,以逐渐的纤维化ILD.
主要方法:
- 关于ILD纤维化最近文献的综述.
- 整合单细胞RNA测序和多组学分析的发现.
- 确定关键的细胞参与者和参与纤维化中的信号通路.
主要成果:
- 纤维化进展涉及上皮细胞损伤,免疫激活和纤维细胞-肌纤维细胞分化.
- 发现的新机制包括固酶4抑制和向自毒素-溶酸轴和整合素.
- 膜内皮细胞,免疫细胞和纤维细胞在渐进性纤维化中起着至关重要的作用.
结论:
- 对渐进性纤维化ILD机制的理解有了显著的进步.
- 针对新途径的新兴疗法在治疗渐进性纤维化ILD方面表现有前途.
更多相关视频
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
124
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.4K
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features
252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Introduction to Fibroblasts
3.1K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.1K
Types of Intermediate Filaments
3.7K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
3.7K
Pulmonary Hypertension: Classification and Pathogenesis
164
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
164
